IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Sep 2004 (Vol: 2004, Issue: 51)

Next Issue >>

Section: Business Commentaries
Getting the Deal Value Right! Published: 1 Sep-2004
By: Fintan Walton
Abstract Fulltext:
Section: Company Profile
Toyama Chemical Co. Ltd. Published: 4 Sep-2004
By: Business Review Editor
Abstract Fulltext:
Section: Deal Trackers
Erbitux (cetuximab) Published: 4 Sep-2004
By: Business Review Editor
Abstract Fulltext:
Section: General
Deltanoid’s and Abbott’s Renal Partnership Published: 4 Sep-2004
By: Business Review Editor
Abstract
Section: Licensing
Structural GenomiX Acquires Troxatyl® from Shire Published: 4 Sep-2004
By: Business Review Editor
Abstract Fulltext:
Agensys and Genentech in Cancer Antibody Agreement Published: 4 Sep-2004
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Mylan to Acquire King for US$4 B Published: 4 Sep-2004
By: Business Review Editor
Abstract Fulltext:
Roche Consumer Health Sold to Bayer Published: 4 Sep-2004
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Takeda and Lexicon Form Hypertension Collaboration Published: 4 Sep-2004
By: Business Review Editor
Abstract Fulltext:
Codexis and Pfizer Collaborate on Pharmaceutical Life Cycle Management Published: 4 Sep-2004
By: Business Review Editor
Abstract Fulltext:

PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.

Login

Username:

Password:

Keep me logged in